Researchers have invented a cheap, portable, microchip-based test for diagnosing type-1 diabetes that could speed up diagnosis and enable studies of how the disease develops.
An inexpensive, portable, microchip-based test for diagnosing type-1 diabetes could improve patient care worldwide and help researchers better understand the disease, according to the device’s inventors at the Stanford University School of Medicine.
Described in a paper published online July 13 inNature Medicine, the test employs nanotechnology to detect type-1 diabetes outside hospital settings. The handheld microchips distinguish between the two main forms of diabetes mellitus, which are both characterized by high blood-sugar levels but have different causes and treatments. Until now, making the distinction has required a slow, expensive test available only in sophisticated health-care settings. The researchers are seeking Food and Drug Administration approval of the device.
“With the new test, not only do we anticipate being able to diagnose diabetes more efficiently and more broadly, we will also understand diabetes better — both the natural history and how new therapies impact the body,” said Brian Feldman, MD, PhD, assistant professor of pediatric endocrinology and the Bechtel Endowed Faculty Scholar in Pediatric Translational Medicine. Feldman, the senior author of the paper, is also a pediatric endocrinologist at Lucile Packard Children’s Hospital Stanford.
Better testing is needed because recent changes in who gets each form of the disease have made it risky to categorize patients based on their age, ethnicity or weight, as was common in the past, and also because of growing evidence that early, aggressive treatment of type-1 diabetes improves patients’ long-term prognoses.
The Latest on: Diabetes
via Google News
The Latest on: Diabetes
- I Struggle with Diabetes. Don’t Call Me 'Non-Compliant'on October 12, 2020 at 6:26 am
There have been some efforts to change the language around diabetes care, but the problem with these terms — and I can’t emphasize this enough — is that even if you don’t mind it, it’s almost always ...
- Mice with diabetes successfully treated with electromagnetic fieldson October 12, 2020 at 12:35 am
Researchers have used electromagnetic fields to treat mice with type 2 diabetes. This finding could potentially lead to new treatments.
- Global Diabetes Injection Pen Market Increasing Demand with Leading Player, Comprehensive Analysis, Forecast 2030on October 11, 2020 at 11:15 pm
Market.us delivers granular analysis of Diabetes Injection Pen Market 2021 Movements by Key Findings, Industry Impact, Latest Trend Analysis, Revenue Expectation to 2030 Research Report by Market.us, ...
- Recall alert: Manufacturers expand diabetes drug recall over excess cancer-causing compound levelson October 11, 2020 at 10:17 pm
Marksans Pharma Ltd. and Sun Pharmaceutical Industries Ltd., both based in India, joined at least eight other companies in voluntarily recalling extended-release metformin since the issue was first ...
- Start your week smart: Coronavirus, diabetes drug, R. Kelly, new iPhone, Columbus Dayon October 11, 2020 at 5:07 am
Here's what else you need to know to Start Your Week Smart. The Senate Judiciary Committee will begin its nomination hearings for Amy Coney Barrett on Monday. Republican leaders are confident that she ...
- Diabetes Drug Recalled Due To High Levels Of Cancer-Causing Contaminanton October 10, 2020 at 2:04 pm
NEW YORK (CBSNewYork/CNN) — A widely-used diabetes drug is being recalled after manufacturers found it contained unacceptably high levels of a cancer-causing contaminant. Indian pharmaceutical company ...
- Diabetes Drug Recalled Due to High Levels of Substance that 'Could Cause Cancer,' FDA Sayson October 10, 2020 at 6:32 am
A drug commonly used to treat Type 2 diabetes has been recalled due to cancer concerns. This week, the Food and Drug Administration announced that Marksans Pharma Limited had expanded its voluntary ...
- Diabetes drug recalled because it may have high levels of cancer-causing compoundon October 9, 2020 at 7:31 pm
Since May, several companies have recalled metformin extended-release tablets over concerns about a cancer-causing chemical.
- Diabetes Foundation Board member encourages public to join Walk for Diabeteson October 9, 2020 at 7:16 pm
HATTIESBURG, Miss. (WDAM) - The Southern Eye Center is encouraging the Hattiesburg community to take part in the 2020 virtual Walk for Diabetes. Retina surgeon Dr. Jaime Jiminez with the center is a ...
- 14 Year Old Girl DJ Wildstyle Hosts American Diabetes Association Los Angeles Virtual Tour De Cure After Party to Raise Awareness and Fundson October 9, 2020 at 2:36 pm
The American Diabetes Association of Los Angeles is having it’s annual Tour de Cure with a twist. While the event on October 18 is virtual this year because of the higher risk of poor outcomes for ...
via Bing News